|
ANKRD50 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.781400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.404560E-03 |
| Normal-vs-Stage2 |
4.668100E-02 |
| Normal-vs-Stage3 |
9.581500E-04 |
| Normal-vs-Stage4 |
4.163800E-04 |
| Stage1-vs-Stage2 |
6.114200E-01 |
| Stage1-vs-Stage3 |
5.119000E-01 |
| Stage1-vs-Stage4 |
2.562200E-01 |
| Stage2-vs-Stage3 |
3.833000E-01 |
| Stage2-vs-Stage4 |
2.088800E-01 |
| Stage3-vs-Stage4 |
5.694600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.232700E-04 |
| Normal-vs-AfricanAmerican |
1.521840E-01 |
| Normal-vs-Asian |
1.944240E-02 |
| Caucasian-vs-AfricanAmerican |
3.117400E-01 |
| Caucasian-vs-Asian |
5.327000E-01 |
| AfricanAmerican-vs-Asian |
6.423200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.841400E-03 |
| Normal-vs-Female |
4.171000E-04 |
| Male-vs-Female |
6.948000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.244000E-03 |
| Normal-vs-Age(41-60Yrs) |
3.577800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.682310E-03 |
| Normal-vs-Age(81-100Yrs) |
1.689690E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.103600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.555600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.155600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.283400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.749800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.737800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.504400E-01 |
| Classical-VS-Follicular |
4.115800E-01 |
| Classical-VS-Other |
6.649600E-01 |
| Classical-VS-Normal |
3.596900E-03 |
| Tall-VS-Follicular |
6.821000E-01 |
| Tall-VS-Other |
9.624200E-01 |
| Tall-VS-Normal |
2.798600E-03 |
| Follicular-VS-Other |
8.831200E-01 |
| Follicular-VS-Normal |
2.679100E-03 |
| Other-VS-Normal |
1.041630E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.567300E-04 |
| Normal-vs-N1 |
8.035600E-04 |
| N0-vs-N1 |
7.065000E-01 |
|
|
